In April 2025, the US Food and Drug Administration (FDA) published a roadmap for leveraging new approach methodologies (NAMs), including in silico approaches such as artificial intelligence (AI), to ...

Imagine a future where artificial intelligence quietly shoulders the drudgery of software development: refactoring tangled ...